SUMMARY A patient with congestive heart failure and moderate renal insufficiency developed severe reversible non-oliguric renal failure while on frusemide and enalapril. Renal failure developed when enalapril was given in the presence of pronounced sodium depletion. When positive sodium balance was restored the plasma creatinine concentration began to fall while angiotensin converting enzyme inhibition remained effective and blood pressure was stable.
Treatment of congestive heart failure with vasodilators, including angiotensin converting enzyme inhibitors, produces both clinical and circulatory improvement.' 2 Recently, however, it has become apparent that renal function may be adversely affected by inhibition of the angiotensin converting enzyme in the treatment of congestive heart failure3'4 or renovascular hypertension.5'6 Disturbances in glomerular autoregulation due to inhibition of angiotensin converting enzyme,7 either alone or in combination with diuretics,3 8 g/dl, calcium 2-28 mmol/l, and glucose 6-5 mmol/l. His haematocrit was 41%, and haemoglobin was 12 8 g/dl. All drugs were discontinued and the patient was given bicarbonate and intravenous saline. The Figure shows the time course of changes in his weight, mean arterial blood pressure, and plasma sodium and creatinine during the days after admission. The initial 24 hour diuresis was 1300ml and remained above 1000ml thereafter. On the first day, plasma renin activity while supine was 33-5 ng/ml/h (25-7 mmol/l/h) (normal range in sodium replete state 0-35-1-30 ng angiotensin I/ml/h (270-1002 pmol/l/h)) and plasma aldosterone while supine was 3X5 ng/dl (normal range in the sodium replete state 5-12 ng/dl (138.5-332.4 pmol/l)). On the first two days, the plasma enalaprilic acid concentration was very high (597 ng/ml and 392 ng/ml respectively; mean (SD) peak value concentration in hypertensive patients with normal renal function who had taken 20 mg enalapril per day for three weeks in our laboratory was 75-6 (25-8) ng/ml). Plasma converting enzyme activity on the second day was significantly reduced at 19 mU/ml (normal: 30-8 (7-5) mU/ml). During the following days the patient's condition improved on water restriction and intravenous bicarbonate and saline. By day eight creatinine clearance was 25 ml/min. Mild intermittent proteinuria (< 150 mg/24 h) was observed but no pyuria, haematuria, or bacteriuria occurred during the patient's stay at this hospital. Renal arteriography showed normal renal arteries; a renal biopsy was not performed. On day 11 the patient experienced dyspnoea, and was given diuretics, digitoxin, and isosorbide dinitrate. Later enalapril (5 mg per day) was added. Five, six, and seven days after enalapril was started the plasma concentration of enalaprilic acid immediately before drug intake was 23 ng/ml, and plasma converting enzyme activity was 6 6 mU/ml. The patient was discharged on isosorbide dinitrate (60mg per day), digitoxin (0-10 mg every two days), enalapril (5mg per day), and frusemide (40mg every two days). His plasma creatinine remained stable at 265 jmol/l for the next two months.
Discussion
This patient developed non-oliguric acute on chronic renal failure during combined treatment with frusemide and enalapril. Renal function slowly deteriorated before the introduction of the angiotensin converting enzyme inhibitor. Because there was no echographic evidence ofobstructive uropathy or a history of chronic nephrotoxic drug adminis-Funck-Brentano, Chatellier, Alexandre tration, the underlying renal disease was presumed to have been nephroangiosclerosis.
In this patient with normal renal arteriography and congestive heart failure, enalapril induced acute renal insufficiency when it was administered after sodium depletion had become pronounced. This suggests that the degree of sodium depletion may play a major role in the propensity of angiotensin converting enzyme inhibitors to induce renal failure. This hypothesis accords with the results of Mujais et al, who found that renal plasma flow and glomerular filtration rate dropped considerably after the first dose of captopril in patients with congestive heart failure who were given diuretics. 3 Creager et al obtained contrasting results in the salt replete state.9 The renin-angiotensin system plays a major role in renal adaptation to sodium depletion7 10 and to congestive heart failure.11 Preservation of glomerular filtration rate by angiotensin II mediated constriction of glomerular efferent arterioles may be the basis of the adaptation to low renal perfusion pressure.7 Angiotensin converting enzyme inhibitors enhance the vasodilatatory actions of prostaglandins and bradykinin"2 and may also contribute to a decreased rate of glomerular filtration. 7 Arterial hypotension leading to renal hypoperfusion and failure cannot be excluded in our patient. Nevertheless, renal failure on a combination of diuretics and angiotensin converting enzyme inhibitors has been reported to occur independently of a drop in blood pressure.38 Finally, the underlying renal disease may also have been an important factor favouring renal failure in the face ofangiotensin converting enzyme inhibition and sodium depletion.
In view of the recovery of renal function in our patient, we believe that the positive sodium balance played a major role. The plasma creatinine concentration began to fall on day two (Fig.) even though inhibition ofangiotensin converting enzyme was still effective, as shown by the very low plasma converting enzyme activity. Moreover, the concentration of plasma enalaprilic acid (the active metabolite of enalapril) remained high (392 ng/ml) on day two. Inhibition of plasma converting enzyme activity is thought to be greatest when plasma enalaprilic acid concentration is > 20 ng/ml.'3 After the resumption of enalapril treatment in our patient, this concentration remained above this threshold without impairing renal function when a new sodium balance had been reached.
Since the mean arterial blood pressure did not change during the first four days (Fig.) 
